Ghrelin and the synthetic growth hormone secretagogues (GHSs) activate a G-protein-coupled receptor (GHS-R) originally cloned from the pituitary, but which is also expressed in the hypothalamus, in other areas of the brain and in numerous peripheral tissues. Several studies have shown that growth hormone (GH)-releasing hormone (GHRH) is necessary for GHSs to exert maximal GH release in vivo. The exact mechanism of this synergism is not clear. Previous data suggest that GHSs can affect pituitary GHS-R mRNA expression; however, it is unknown whether this effect is age dependent and whether hypothalamic GHS-Rs are also affected. In this study, we tested whether (a) the synthetic GHS hexarelin regulates mRNA expression of its own receptor at the pituitary and/or hypothalamus and whether this effect is age dependent, and (b) whether short-term treatment with GHRH or, conversely, passive immunization against GHRH affects pituitary GHS-R1a mRNA expression in infant (10 days old) and young adult rats. GHS-R1a mRNA expression was measured with competitive reverse transcriptase-polymerase chain reaction. Hexarelin treatment significantly increased pituitary and hypothalamic GHS-R1a mRNA levels in normal infant rats, but not in normal young adult rats. In addition, hexarelin administration also stimulated pituitary GHS-R1a mRNA in infant as well as in young adult rats passively immunized against GHRH. GHRH treatment significantly enhanced pituitary GHS-R1a mRNA expression in GHRH-deprived young adult rats, though it did not affect the basal levels of GHS-R1a mRNA in normal infant and adult rats. These data further support the hypothesis that GHRH can affect GHS-R1a expression and that hexarelin upregulates the expression of its own receptor at the pituitary as well as the hypothalamus in an age-dependent fashion.

Keywords:
Growth hormone-releasing hormone, Growth hormone secretagogues, Molecular neuroendocrinology
1.
Arvat E, Broglio F, Aimaretti G, Benso A, Giordano R, Deghenghi R, Ghigo E: Ghrelin and synthetic GH secretagogues. Best Pract Res Clin Endocrinol Metab 2002;16:505–517.
2.
Howard AD, Feighner SD, Cully DF, Arena JP, Liberator PA, Rosenblum CI, Hamelin MJ, Hreniuk DL, Palyha OC, Anderson J, Paress PS, Diaz C, Chou M, Liu K, McKee KK, Pong SS, Chaung LY, Elbrecht A, Dashkevicz M, Haevens R, Rigby M, Sirinathsinghji DJS, Dean DC, Melillo D G, Patchett AA, Nargund R, Griffin PR, De Martino JA, Gupta SK, Schaeffer JM, Smith RG, Van der Ploeg LHT: A receptor in pituitary and hypothalamus that functions in growth hormone release. Science 1996;273:974–977.
3.
Blake AD, Smith RG: Desensitization studies using perifused rat pituitary cells show that growth hormone-releasing hormone and His-D-Trp-Ala-Trp-D-Phe-Lys-NH2 stimulate growth hormone release through distinct receptor sites. J Endocrinol 1991;129:11–19.
4.
Muccioli G, Ghè C, Ghigo MC, Papotti M, Arvat E, Boghen MF, Nilsson MHL, Deghenghi R, Ong H, Ghigo E: Specific receptors for synthetic GH secretagogues in the human brain and pituitary gland. J Endocrinol 1998;157:99–106.
5.
Gnanapavan S, Kola B, Bustin SA, Morris DG, McGee P, Fairclough P, Bhattacharya S, Carpenter R, Grossman AB, Korbonits M: The tissue distribution of the mRNA of ghrelin and subtypes of its receptor, GHS-R, in humans. J Clin Endocrinol Metab 2002;87:2988–2991.
6.
Kojima M, Hosoda H, Date Y, Nakazato M, Matsuo H, Kangawa K: Ghrelin is a growth-hormone-releasing acylated peptide from stomach. Nature 1999;402:656–660.
7.
Rindi G, Necchi V, Savio A, Torsello A, Zoli M, Locatelli V, Raimondo F, Cocchi D, Solcia E: Characterisation of gastric ghrelin cells in man and other mammals: Studies in adult and fetal tissues. Histochem Cell Biol 2002;117:511–519.
8.
Tolle V, Zizzari P, Tomasetto C, Rio MC, Epelbaum J, Bluet-Pajot MT: In vivo and in vitro effects of ghrelin/motilin-related peptide on growth hormone secretion in the rat. Neuroendocrinology 2001;73:54–61.
9.
Seoane LM, Tovar S, Baldelli R, Arvat E, Ghigo E, Casanueva FF, Dieguez C: Ghrelin elicits a marked stimulatory effect on GH secretion in free-moving rats. Eur J Endocrinol 2000;143:R7–R9.
10.
Arvat E, Di Vito L, Broglio F, Papotti M, Muccioli G, Dieguez C, Casanueva FF, Deghenghi R, Camanni F, Ghigo E: Preliminary evidence that ghrelin, the natural growth hormone secretagogue (GHS)-receptor ligand, strongly stimulates GH secretion in humans. J Endocrinol Invest 2000;23:493–495.
11.
Müller EE, Locatelli V, Cocchi D: Neuroendocrine control of growth hormone secretion. Physiol Rev 1999;79:511–607.
12.
Shuto Y, Shibasaki T, Otagiri A, Kuriyama H, Ohata H, Tamura H, Kamegai J, Sugihara H, Oikawa S, Wakabayashi I: Hypothalamic growth hormone secretagogue receptor regulates growth hormone secretion, feeding, and adiposity. J Clin Invest 2002;109:1429–1436.
13.
Horn F, Vriend G, Cohen FE: Collecting and harvesting biological data: The GPCRDB and NucleaRDB information systems. Nucleic Acids Res 2001;29:346–349.
14.
Toth DW, Hellmann PH, Gordon DA, Suslarchyk D, Qu F, Tino J, Thorner MO: Evidence that the orexigenic effect of ghrelin is mediated by a distinct GHS-R subtype. Proc 83rd Meet Endocr Soc, Denver, 2001.
15.
Baldanzi G, Filigheddu N, Cutrupi S, Catapano F, Bonissoni S, Fubini A, Malan D, Baj G, Granata R, Broglio F, Papotti M, Surico N, Bussolino F, Isgaard J, Deghenghi R, Sinigaglia F, Prat M, Muccioli G, Ghigo E, Graziani A: Ghrelin and des-acyl ghrelin inhibit cell death in cardiomyocytes and endothelial cells through ERK1/2 and PI 3-kinase/AKT. J Cell Biol 2002;159:1029–1037.
16.
Lei T, Buchfelder M, Fahlbusch R, Adams EF: Growth hormone releasing peptide (GHRP-6) stimulates phosphatidylinositol (PI) turnover in human pituitary somatotroph cells. J Mol Endocrinol 1995;14:135–138.
17.
Mau SE, Witt MR, Bjerrum OJ, Saermark T, Vilhardt H: Growth hormone releasing hexapeptide (GHRP-6) activates the inositol (1,4,5)-trisphosphate/diacylglycerol pathway in rat anterior pituitary cells. J Recept Signal Transduct Res 1995;15:311–323.
18.
Nass R, Gilrain J, Anderson S, Gaylinn B, Dalkin A, Day R, Peruggia M, Thorner MO: High plasma growth hormone (GH) levels inhibit expression of GH secretagogue receptor messenger ribonucleic acid levels in the rat pituitary. Endocrinology 2000;141:2084–2089.
19.
Kineman RD, Kamegai J, Frohman L: Growth hormone (GH)-releasing hormone (GHRH) and the GH secretagogue (GHS), L692,585, differentially modulate rat pituitary GHS receptor and GHRH receptor messenger ribonucleic acid levels. Endocrinology 1999;140:3581–3586.
20.
Tannenbaum GS, Epelbaum J, Bowers CY: Interrelationship between the novel peptide ghrelin and somatostatin/growth hormone-releasing hormone in regulation of pulsatile growth hormone secretion. Endocrinology 2003;144:967–974.
21.
Maheshwari HG, Pezzoli SS, Rahim A, Shalet SM, Thorner MO, Baumann G: Pulsatile growth hormone secretion persists in genetic growth hormone-releasing hormone resistance. Am J Physiol Endocrinol Metab 2002;282:E943–E951.
22.
Pombo M, Barreiro P, Peino R, Dieguez C, Casanueva FF: Absence of growth hormone (GH) secretion after the administration of either GH-releasing hormone (GHRH), GH-releasing peptide (GHRP-6), or GHRH plus GHRP-6 in children with neonatal pituitary stalk transection. J Clin Endocrinol Metab 1995;80:3180–3184.
23.
Conley LK, Teik JA, Deghenghi R, Imbimbo BP, Giustina A, Locatelli V, Wehrenberg WB: Mechanism of action of hexarelin and GHRP-6: Analysis of the involvement of GHRH and somatostatin in the rat. Neuroendocrinology 1995;61:44–50.
24.
Pandya N, De Mott-Friberg R, Bowers CY, Barkan AL, Jaffe CA: Growth hormone (GH)-releasing peptide-6 requires endogenous hypothalamic GH-releasing hormone for maximal GH stimulation. J Clin Endocrinol Metab 1998;83:1186–1189.
25.
Wehrenberg WB, Bloch B, Phillips BJ: Antibodies to growth hormone-releasing factor inhibits somatic growth. Endocrinology 1984;115:1218–1220.
26.
Cella SG, Locatelli V, Mennini T, Zanini A, Bendotti C, Forloni GL, Fumagalli G, Arce VM, Wehrenberg WB, Müller EE: Deprivation of growth hormone-releasing hormone early in the rats neonatal life permanently affects somatotropic function. Endocrinology 1990;127:1625–1634.
27.
Wehrenberg WB, Voltz DM, Cella SG, Müller EE, Gaillard RC: Long-term failure of compensatory growth in rats following acute neonatal passive immunization against growth hormone-releasing hormone. Neuroendocrinology 1992;56:509–515.
28.
Hataya Y, Akamizu T, Takaya K, Kanamoto N, Ariyasu H, Saijo M, Moriyama K, Shimatsu A, Kojima M, Kangawa K, Nakao K: A low dose of ghrelin stimulates growth hormone (GH) release synergistically with GH-releasing hormone in humans. J Clin Endocrinol Metab 2001;86:4552–4555.
29.
Arvat E, Maccario M, Di Vito L, Broglio F, Benso A, Gottero C, Papotti M, Muccioli G, Dieguez C, Casanueva FF, Deghenghi R, Camanni F, Ghigo E: Endocrine activities of ghrelin, a natural growth hormone secretagogue (GHS), in humans: comparison and interactions with hexarelin, a nonnatural peptidyl GHS, and GH-releasing hormone. J Clin Endocrinol Metab 2001;86:1169–1174.
30.
Cunha SR, Mayo KE: Ghrelin and growth hormone (GH) secretagogues potentiate GH-releasing hormone (GHRH)-induced cyclic adenosine 3′,5′-monophosphate production in cells expressing transfected GHRH and GH secretagogue receptors. Endocrinology 2002;143:4570–4582.
31.
Torsello A, Luoni M, Grilli R, Guidi M, Wehrenberg WB, Deghenghi R, Müller EE, Locatelli V: Hexarelin stimulation of growth hormone release and mRNA levels in an infant and adult rat model of impaired GHRH function. Neuroendocrinology 1997;65:91–97.
32.
Arvat E, Camanni F, Ghigo E: Age-related growth hormone-releasing activity of growth hormone secretagogues in humans. Acta Paediatr Suppl 1997;423:92–96.
33.
Katayama M, Nogami H, Nishiyama J, Kawase T, Kawamura K: Developmentally and regionally regulated expression of growth hormone secretagogue receptor mRNA in rat brain and pituitary gland. Neuroendocrinology 2000;72:333–340.
34.
Kamegai J, Wakabayashi I, Kineman RD, Frohman LA: Growth hormone-releasing hormone receptor (GHRH-R) and growth hormone secretagogues receptor (GHS-R) mRNA levels during postnatal development in male and female rats. J Endocrinol 1999;11:299–306.
35.
Deghenghi R, Cananzi MM, Torsello A, Battisti C, Muller EE, Locatelli V: GH-releasing activity of Hexarelin, a new growth hormone releasing peptide, in infant and adult rats. Life Sci 1994;54:1321–1328.
36.
Cella SG, De Gennaro Colonna V, Locatelli V, Bestetti GE, Rossi GL, Torsello A, Wehrenberg WB, Muller EE: Somatotropic dysfunction in growth hormone-releasing hormone-deprived neonatal rats: Effect of growth hormone replacement therapy. Pediatr Res 1994;36:315–322.
37.
Bennet PA, Thomas GB, Howard AD, Feighner SD, Van der Ploeg LHT, Smith RG, Robinson ICAF: Hypothalamic growth hormone secretagogue-receptor (GHS-R) expression is regulated by growth hormone in the rat. Endocrinology 1997;138:4552–4557.
38.
Grilli R, Ghigo MC, Torsello A, Guidi M, Luoni M, Locatelli V, Müller EE: Effects of GH and IGF-1 administration on GHRH and somatostatin mRNA levels. 2. A study in the infant rat. J Endocrinol Invest 1997;20:151–154.
39.
Cella SG, Locatelli V, De Gennaro V, Puggioni R, Pintor C, Muller EE: Human pancreatic growth hormone (GH)-releasing hormone stimulates GH synthesis and release in infant rats. An in vivo study. Endocrinology 1985;116:574–577.
40.
Ong H, Esher E, Collu R, Deghenghi R, Locatelli V, Ghigo E, Muccioli G, Boghen M, Nillson M: Identification of a pituitary growth hormone-releasing peptide receptor subtype by photoaffinity labeling. Endocrinology 1998;139:432–435.
41.
Bodart V, Bouchard JF, McNicoll N, Esher E, Carriere P, Ghigo E, Sejlitz T, Sirois M G, Lamontagne D, Ong H: Identification and characterization of a new growth hormone-releasing peptide receptor in the heart. Circ Res 1999;85:796–802.
42.
Bodart V, Febbraio M, Demers A, McNicoll N, Pohankova P, Perreault A, Sejlitz T, Esher E, Silverstein RL, Lamontagne D, Ong H: CD 36 mediates the cardiovascular action of growth hormone-releasing peptides in the heart. Circ Res 2002;90:844–849.
43.
Hurley DL, Reynolds GA, Veldhuis JD, Bowers CY: Long-term GH-releasing peptide-1 treatment increases pituitary GH mRNA. 85th Endocr Soc Meet, Philadelphia, 2003.
44.
Torsello A, Scibona B, Leo G, Bresciani E, Avallone R, Bulgarelli I, Luoni M, Zoli M, Rindi G, Cocchi D, Locatelli V: Ontogeny and tissue-specific regulation of ghrelin mRNA expression suggest that ghrelin is primarily involved in the control of extraendocrine functions in the rat. Neuroendocrinology 2003;77:91–99.
© 2004 S. Karger AG, Basel
2004
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.